Effects of ganglionic blocking agents on adrenergic transmission in rat mesenteric arteries.
D000109:Acetylcholine; D000818:Animals; D001285:Atropine / Q000494:pharmacology; D001338:Autonomic Fibers, Postganglionic / Q000187:drug effects; D002118:Calcium; D004305:Dose-Response Relationship, Drug; D004357:Drug Synergism; D005260:Female; D006584:Hexamethonium Compounds / Q000494:pharmacology*; D008638:Mesenteric Arteries / Q000187:drug effects / Q000294:innervation; D009130:Muscle, Smooth / Q000294:innervation; D009638:Norepinephrine / Q000494:pharmacology; D051381:Rats; D011941:Receptors, Adrenergic / Q000187:drug effects; D013564:Sympathetic Nervous System / Q000187:drug effects* / Q000502:physiology; D009435:Synaptic Transmission / Q000187:drug effects*; D013757:Tetraethylammonium Compounds / Q000494:pharmacology*; D014439:Tyramine / Q000494:pharmacology; D014666:Vasomotor System / Q000187:drug effects
D006584:Hexamethonium Compounds; D011941:Receptors, Adrenergic; D013757:Tetraethylammonium Compounds; D001285:Atropine; D000109:Acetylcholine; D002118:Calcium; D009638:Norepinephrine; D014439:Tyramine